Abstract
We describe the case of a 15-y-old boy with a post-surgical osteoarticular infection, who developed a severe neutropenia after 24 days of treatment with cefepime. Our report suggests that, although rare, severe neutropenia should be considered by clinicians when prescribing cefepime, especially if long-term therapy is expected.
MeSH terms
-
Adolescent
-
Anti-Bacterial Agents / adverse effects*
-
Anti-Bacterial Agents / therapeutic use*
-
Cefepime
-
Cephalosporins / adverse effects*
-
Cephalosporins / therapeutic use*
-
Humans
-
Male
-
Neutropenia / chemically induced*
-
Osteoarthritis / drug therapy
-
Surgical Wound Infection / drug therapy
Substances
-
Anti-Bacterial Agents
-
Cephalosporins
-
Cefepime